Mutations
TREM2 c.40+3 delAGG
Quick Links
Overview
Pathogenicity: Frontotemporal Dementia : Pathogenic
Clinical
Phenotype: Frontotemporal Dementia
Position: (GRCh38/hg38):Chr6:41163040_41163038 AGG>---
Position: (GRCh37/hg19):Chr6:41130776_41130778 AGG>---
dbSNP ID: NA
Coding/Non-Coding: Non-Coding
DNA
Change: Deletion
Expected RNA
Consequence: Splicing Alteration
Genomic
Region: Intron 1
Findings
This variant creates a three-nucleotide deletion in the 5′ consensus donor splice site in intron 1. The homozygous variant was identified in three siblings affected by early onset dementia, members of a consanguineous Lebanese family (Chouery et al., 2008). Symptom onset occurred at 30–35 years of age, and included forgetfulness, fatigue, lack of initiative, and inability to perform activities of daily living. Clinical progression was characterized by euphoria, loss of social inhibition, and incontinence, followed by severe dementia. One patient died at age 50, a second at age 46 due to respiratory infection, and the third was in a vegetative state at age 50. Additional genotyping of 11 unaffected family members showed that this sequence variation segregated with the disease phenotype. The variant was not found in 200 control chromosomes from Lebanese subjects.
Neuropathology
Neuropathological characterization of patients carrying this variant is currently lacking. However, MRI revealed brain atrophy, including thinning of the corpus callosum, but not the calcification typically seen in Nasu-Hakola disease; nor were bone cysts seen in these patients (Chouery et al., 2008).
Biological Effect
This variant resulted in a greater than twofold reduction in the level of TREM2 transcripts in lymphocytes and fibroblasts, as compared to controls. Abnormal transcripts were not detected, but the authors could not rule out the possibility that the variant leads to some degree of aberrant splicing (Chouery et al., 2008).
Last Updated: 07 Feb 2018
References
Paper Citations
- Chouery E, Delague V, Bergougnoux A, Koussa S, Serre JL, Mégarbané A. Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum Mutat. 2008 Sep;29(9):E194-204. PubMed.
Further Reading
No Available Further Reading
Protein Diagram
Primary Papers
- Chouery E, Delague V, Bergougnoux A, Koussa S, Serre JL, Mégarbané A. Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum Mutat. 2008 Sep;29(9):E194-204. PubMed.
Alzpedia
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.